|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 88.44 GBX | -1.63% |
|
+0.84% | -6.91% |
| 02-12 | Who is Sanofi's new CEO Belén Garijo? | RE |
| 02-05 | Syncona hails biotech recovery ahead of dividend policy vote | AN |
| Capitalization | 538M 731M 619M 571M 1B 68.12B 1.02B 6.69B 2.62B 32.7B 2.74B 2.68B 116B | P/E ratio 2024 |
216x | P/E ratio 2025 | -3.73x |
|---|---|---|---|---|---|
| Enterprise value | 537M 729M 618M 570M 1B 67.98B 1.02B 6.68B 2.62B 32.64B 2.74B 2.68B 116B | EV / Sales 2024 |
26.2x | EV / Sales 2025 | -4.39x |
| Free-Float |
99.22% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Syncona Limited
| 20/06/25 | UBS cuts Hays and PageGroup to 'neutral' | AN |
| 24/04/25 | Jefferies Upgrades Syncona to Buy | MT |
| 03/05/24 | Jefferies cuts AJ Bell; Deutsche likes ConvaTec | AN |
| 1 day | -1.33% | ||
| 1 week | +0.84% | ||
| Current month | -0.07% | ||
| 1 month | -6.02% | ||
| 3 months | -11.56% | ||
| 6 months | -11.39% | ||
| Current year | -6.91% |
| 1 week | 86.9 |  | 91.9 |
| 1 month | 86.9 | | 97.4 |
| Current year | 86.9 | | 101 |
| 1 year | 79.6 | | 102.6 |
| 3 years | 77.32 | | 162.2 |
| 5 years | 77.32 | | 248.5 |
| 10 years | 77.32 | | 306.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
John Tsai
PRN | Corporate Officer/Principal | 59 | 31/12/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Gian Reverberi
BRD | Director/Board Member | 60 | 31/03/2018 |
Melanie Gee
CHM | Chairman | 65 | 03/06/2019 |
Kemal Malik
BRD | Director/Board Member | 63 | 14/06/2020 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.63% | +0.84% | -0.52% | -41.43% | 742M | |
| +0.13% | +2.53% | +34.91% | +74.52% | 125B | |
| +1.08% | +1.22% | +31.21% | +17.14% | 27.85B | |
| -0.02% | +0.94% | +53.83% | +64.91% | 23.28B | |
| -0.46% | +0.35% | +50.61% | +42.40% | 18.43B | |
| +2.87% | +9.18% | -11.60% | +10.99% | 15.81B | |
| +0.86% | +1.91% | +15.69% | +16.30% | 15.01B | |
| +1.36% | +1.19% | +4.12% | +167.19% | 13.41B | |
| +1.70% | +2.49% | -13.75% | +71.58% | 11.99B | |
| -2.12% | +2.05% | +46.44% | +156.55% | 11.78B | |
| Average | +0.42% | +1.76% | +21.09% | +58.02% | 26.36B | |
| Weighted average by Cap. | +0.42% | +1.74% | +30.04% | +66.16% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 30.75M 41.75M 35.36M 32.61M 57.35M 3.89B 58.28M 382M 150M 1.87B 157M 153M 6.63B | -121M -165M -140M -129M -227M -15.37B -230M -1.51B -591M -7.38B -619M -606M -26.2B |
| Net income | 3.79M 5.14M 4.36M 4.02M 7.07M 479M 7.18M 47.11M 18.44M 230M 19.29M 18.89M 817M | -143M -194M -165M -152M -267M -18.12B -271M -1.78B -697M -8.7B -729M -714M -30.88B |
| Net Debt | -261K -354K -300K -277K -487K -33.03M -495K -3.25M -1.27M -15.86M -1.33M -1.3M -56.3M | -1.11M -1.51M -1.28M -1.18M -2.08M -141M -2.11M -13.84M -5.42M -67.62M -5.67M -5.55M -240M |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/04/26 | 88.44 p | -1.63% | 214,227 |
| 15/04/26 | 89.90 p | -1.64% | 258,488 |
| 14/04/26 | 91.40 p | +3.86% | 274,029 |
| 13/04/26 | 88.00 p | +1.27% | 107,456 |
| 10/04/26 | 86.90 p | -0.91% | 311,422 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Equities
- BACT Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition